ROCHESTER, N.Y., June 16, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational firm working companies specializing in model safety expertise, blockchain safety, direct advertising and marketing, healthcare, shopper packaging, actual property, renewable vitality, and securitized digital property, at the moment introduced its wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”) acquired discover of issuance (US 10,966,424) from the U.S. Patent and Trademark Office (“USPTO”) for 3FDB, a Functional Fragrance Formulation (3F) expertise that will increase the effectiveness of present mosquito repellants by means of a delightfully aromatic compound derived from botanical oils.3FDB is an efficacy booster for present mosquito repellants akin to DEET, Picaridin, and IR3535, amongst others. The booster incapacitates two of the three receptors that mosquitos use to seek out sources of vitamin, on this case, that supply is people.“While present mosquito repellants goal solely the gustatory receptors in bugs, 3FDB makes use of a a number of receptor strategy by focusing on ionotropic, gustatory and olfactory receptors in bugs to supply a synergistic motion to repel bugs in addition to inhibit the power of bugs to detect and search prey,” says Daryl Thompson, Director of Scientific Initiatives at Impact BioMedical and founding father of superior analysis firm GRDG Sciences, LLC (“GRDG”).While 3FDB has far-reaching purposes for on a regular basis life, an important utility could possibly be saving lives. According to the National Institutes of Health, mosquitos are accountable for greater than one million deaths annually as a result of they will host a wide range of illnesses together with malaria, dengue, West Nile yellow fever, Zika, chikungunya, and lymphatic filariasis.Impact BioMedical’s Chief Scientific Advisor Dr. Roscoe M. Moore, Jr., United States Assistant Surgeon General (Retired) and former Epidemic Intelligence Service (EIS) Officer at U.S. Centers for Disease Control and Prevention, stated, “This patent might pave the way in which for elevated safety from mosquito-borne illnesses all over the world.”Story continuesThe want to avoid wasting lives was the impetus that led Impact BioMedical to hunt an answer to this international well being drawback. The Florida-based crew discovered it proper in their very own yard.How It Was FoundImpact BioMedical discovered its answer to minimizing mosquito bites in orchids — particularly the elusive and legendary ghost orchid flower — discovered solely within the wild in Cuba and the Florida Everglades.“We checked out over 300 uncommon orchids from all over the world — from Borneo to the Congo to South and Central America — in addition to our personal Florida Everglades,” stated Thompson. “We noticed that whereas the mosquitos had been plentiful in these environments, not one of the males had been ever interested in or pollinating the orchids. The orchids had been principally invisible to the mosquitos.”The crew theorized that the orchids had been producing a chemical that inhibited the mosquitos’ potential to seek out them. Through testing and analysis, the crew recognized the chemical compounds then labored backwards to discover a solution to isolate and reproduce them.“3FDB works otherwise from conventional insect repellents. It’s efficient even at very low concentrations because of its multi-aspect receptor inhibition,” stated Thompson.How It WorksMosquitos have a trio of receptors — ionotropic, gustatory, and olfactory — that detect the chemical substances and carbon dioxide people expel by means of perspiration and respiration. Existing mosquito repellents focus primarily on the gustatory receptor, which diminishes the mosquito’s potential to detect people, however nonetheless leaves the opposite two receptors — ionotropic and olfactory — lively.3FDB, utilizing the replicated chemical compounds discovered within the ghost orchid, focuses on the opposite two receptors, and offers additional safety for the third. The booster blocks the insect’s potential to detect people, basically making people invisible to the mosquito.“We are consistently pushing to remain forward of points affecting the world and look for methods to supply secure and significant options to fight these issues,” stated Mr. Chan Heng Fai, Chairman of DSS.Long-Term FunctionsThe crew relied on the experience of its companions at Chemia Corporation to make use of the chemical compounds of the orchid as the bottom for 3FDB’s deliberately gentle and nice scent.“This collaboration has confirmed the facility of analysis, and perfume is a brand new frontier in modern expertise,” stated Thomas A. Meyer, Vice President, Innovation and Sustainability, Chemia Corporation.3FDB will be included in a wide range of purposes, akin to sprays, lotions, laundry detergents, shampoos, soaps, cloth softeners, dryer sheets, misters, air flow techniques, and air fresheners.According to Statista, the US market for mosquito repellants is forecasted to be $860 million in 2021, rising to $1.2 billion by 2025. Globally, the market is predicted to surpass $6 billion by 2027.”We are happy with the current challenge of our 3F composition patent for a pure insect repellent,” stated Frank Heuszel, CEO of DSS and President of Impact BioMedical. “There is critical curiosity in repellents from botanical sources, and this achievement demonstrates our intent to make these distinctive merchandise accessible to customers worldwide sooner or later.”About Impact BioMedical, Inc.Impact BioMedical, Inc. (“Impact BioMedical”) is a completely owned subsidiary of DSS and a singular expertise supply, developer, and enterprise accomplice in addressing unmet wants in human healthcare and wellness. For extra info on Impact BioMedical go to http://impbio.com/.About Document Security Systems, Inc.DSS is a multinational firm working companies centered on model safety expertise, blockchain safety, direct advertising and marketing, healthcare, shopper packaging, actual property, renewable vitality, and securitized digital property. Its enterprise mannequin is predicated on a distribution sharing system by which shareholders will obtain shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic enterprise revolves round counterfeit deterrent and authentication applied sciences, good packaging, and shopper product engagement. DSS is led by its Chairman and largest shareholder, Mr. Fai Chan, a extremely profitable international enterprise veteran of greater than 40 years specializing in company transformation whereas managing danger. He has efficiently restructured greater than 35 companies with a mixed worth of $25 billion.For extra info on DSS go to http://www.dsssecure.com.Investor Contact:Dave Gentry, CEORedChip Companies [email protected] Harbor DisclosureThis press launch accommodates forward-looking statements which can be made pursuant to the secure harbor provisions inside the which means of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements embody, however should not restricted to, statements associated to the Company’s potential to finish the financing, its meant use of proceeds and different statements that aren’t historic info. Forward-looking statements are primarily based on administration’s present expectations and are topic to dangers and uncertainties that will trigger precise outcomes or occasions to vary materially from these projected. These dangers and uncertainties, lots of that are past our management, embody: the danger that the general public providing of widespread inventory might not shut; dangers regarding our development technique; our potential to acquire, carry out below and preserve financing and strategic agreements and relationships; dangers regarding the outcomes of improvement actions; our potential to draw, combine and retain key personnel; our want for substantial further funds; patent and mental property issues; competitors; in addition to different dangers described within the part entitled “Risk Factors” within the prospectus and in our different filings with the SEC, together with, with out limitation, our reviews on Forms 8-Okay and 10-Q, all of which will be obtained on the SEC web site at www.sec.gov. Readers are cautioned to not place undue reliance on the forward-looking statements, which converse solely as of the date on which they’re made and replicate administration’s present estimates, projections, expectations and beliefs. We expressly disclaim any obligation or enterprise to launch publicly any updates or revisions to any forward-looking statements contained herein to replicate any change in our expectations or any modifications in occasions, situations or circumstances on which any such assertion is predicated, besides as required by regulation.
